[1]
J. Moayedi, T. Hashempour, Z. Musavi, B. Dehghani, Z. Hasanshahi, and S. Merat, “The Predictive Factors for Favorable Outcomes of Peginterferon and Ribavirin Combination Therapy in HCV-Infected Patients”, Acta Med Iran, vol. 58, no. 5, pp. 214-220, Aug. 2020.